Featured

Life sciences sees healthy competition from lenders

Continued demand for medical and life sciences space has investors partnering with private credit and alternative financing providers.

Real estate’s real-time data challenge

Smart buildings and the Internet of Things promise a real estate revolution, but that’s only if operators and investors can handle the live insights these systems are producing.

Core US life sciences markets receive clean bill of health

Demand is expected to return soon to the ‘big three’ – Boston, San Francisco and San Diego.

Pharmaceutical firms’ interest in AI brings shift in property requirements

Many R&D firms are moving from traditional lab spaces to premises that offer sufficient power and network capabilities.

Understanding occupier trends vital for life sciences’ future

High supply means life sciences tenants can call the shots, so meeting evolving user needs is paramount for investors.

The future is bright for life sciences property

In 2024, market vacancies increased with new construction delivered vacant, but this trend should reverse as demand and supply return to more manageable levels.

Proptech fundraising climbs again

Driven primarily by a few large funds, capital accumulation in the proptech space has risen again despite difficult circumstances.

Life sciences sees signs of recovery

Venture capital funding is rebounding, which is driving rental growth.

Investment appetite remains for life sciences real estate

Year-on-year sales volume for lab, R&D space has continued to fall, but a turnaround is expected.

Breaking down the barriers to proptech

The sector holds huge potential for transforming the real estate industry, but some firms are finding that implementing it is not always straightforward.